Publications | Lund University Publications

1 – 10 of 14

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Linder%2C+Olle%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Linder%2C+Olle%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2020
Mark Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
Wålinder, Göran ; Samuelsson, Jan ; Näsman, Per ; Hansson, Markus ^LU ; Juliusson, Gunnar ^LU ; Forsberg, Karin ; Svensson, Ronald ; Linder, Olle ; Carlson, Kristina and Kristinsson, Sigurdur Y. , et al. (2020) In European Journal of Haematology 104(5). p.376-382
- Contribution to journal › Article
2018
Mark Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry
Blimark, Cecilie Hveding ; Turesson, Ingemar ^LU ; Genell, Anna ; Ahlberg, Lucia ; Björkstrand, Bo ; Carlson, Kristina ; Forsberg, Karin ; Juliusson, Gunnar ^LU ; Linder, Olle and Mellqvist, Ulf Henrik , et al. (2018) In Haematologica 103(3). p.506-513
- Contribution to journal › Article
2017
Mark Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register
Nahi, Hareth ; Genell, Anna ; Wålinder, Göran ; Uttervall, Katarina ; Juliusson, Gunnar ^LU ; Karin, Forsberg ; Hansson, Markus ^LU ; Svensson, Ronald ; Linder, Olle and Carlson, Kristina , et al. (2017) In European Journal of Haematology 99(3). p.216-222
- Contribution to journal › Article
2011
Mark Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Mollgard, Lars ; Saft, Leonie ; Treppendahl, Marianne Bach ; Dybedal, Ingunn ; Norgaard, Jan Maxwell ; Astermark, Jan ^LU ; Ejerblad, Elisabeth ; Garelius, Hege ; Dufva, Inge Hogh and Jansson, Monika , et al. (2011) In Haematologica 96(7). p.963-971
- Contribution to journal › Article
2010
Mark Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
Grovdal, Michael ; Karimi, Mohsen ; Khan, Rasheed ; Aggerholm, Anni ; Antunovic, Petar ; Astermark, Jan ^LU ; Bernell, Per ; Engstrom, Lena-Maria ; Kjeldsen, Lars and Linder, Olle , et al. (2010) In British Journal of Haematology 150(3). p.293-302
- Contribution to journal › Article
Mark Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
Gimsing, Peter ; Carlson, Kristina ; Turesson, Ingemar ^LU ; Fayers, Peter ; Waage, Anders ; Vangsted, Annette ; Mylin, Anne ; Gluud, Christian ; Juliusson, Gunnar and Gregersen, Henrik , et al. (2010) In The Lancet Oncology 11(10). p.973-982
- Contribution to journal › Article
Mark Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
Waage, Anders ; Gimsing, Peter ; Fayers, Peter ; Abildgaard, Niels ; Ahlberg, Lucia ; Bjorkstrand, Bo ; Carlson, Kristina ; Dahl, Inger Marie ; Forsberg, Karin and Gulbrandsen, Nina , et al. (2010) In Blood 116(9). p.1405-1412
- Contribution to journal › Article
2009
Mark Lenalidomide in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia with Chromosome 5 Abnormalities
Mollgard, Lars ; Nilsson, Lars ^LU ; Kjeldsen, Lars ; Dybedal, Ingunn ; Dufva, Inge Hogh ; Garelius, Hege ; Norgaard, Jan Maxwell ; Linder, Olle ; Ejerblad, Elisabeth and Astermark, Jan , et al. (2009) 51st Annual Meeting of the American-Society-of-Hematology In Blood 114(22). p.52-52
- Contribution to journal › Published meeting abstract
Mark Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial
Mellqvist, Ulf-Henrik ; Westin, Jan ; Gimsing, Peter ; Hjertner, Oyvind ; Lenhoff, Stig ^LU ; Laane, Edward ; Remes, Kari ; Steingrimsdottir, Hlif ; Abildgaard, Niels and Ahlberg, Lucia , et al. (2009) 51st Annual Meeting of the American-Society-of-Hematology In Blood 114(22). p.221-221
- Contribution to journal › Published meeting abstract
2008
Mark Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
Grovdal, Michael ; Khan, Rasheed ; Aggerholm, Anni ; Antunovic, Petar ; Astermark, Jan ^LU ; Bernell, Per ; Engstroem, Lena-Maria ; Kjeldsen, Lars ; Linder, Olle and Nilsson, Lars , et al. (2008) 50th Annual Meeting of the American- Society-of-Hematology In Blood 112(11). p.89-89
- Contribution to journal › Published meeting abstract

« previous
1
2
next »

your query:: Remove author: Linder, Olle